Sub-stratification of type-2 high airway disease for therapeutic decision-making: a ‘bomb' (blood eosinophils) meets ‘magnet' (FeNO) framework
Prif Awduron: | Couillard, S, Pavord, I, Heaney, L, Petousi, N, Hinks, T |
---|---|
Fformat: | Journal article |
Iaith: | English |
Cyhoeddwyd: |
Wiley
2022
|
Eitemau Tebyg
-
FeNO non-suppression identifies corticosteroid-resistant type-2 signaling in severe asthma
gan: Couillard, S, et al.
Cyhoeddwyd: (2021) -
FeNO non-suppression identifies corticosteroid-resistant type-2 signaling in severe asthma
gan: Couillard, S, et al.
Cyhoeddwyd: (2021) -
Longitudinal changes in sputum and blood inflammatory mediators during FeNO suppression testing
gan: Couillard, S, et al.
Cyhoeddwyd: (2022) -
Mechanisms of FeNO non-suppression in severe asthma: analysis of sputum type 2 cytokines and chemokines
gan: Couillard, S, et al.
Cyhoeddwyd: (2020) -
Feno and blood eosinophils as biomarkers in predicting asthma exacerbations
gan: Rastogi, S, et al.
Cyhoeddwyd: (2017)